Information about Serie
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0420.366.623

VAT liability
Yes
Established
10-04-1980
Last balance sheet year
2024
Company size
Medium-sized 1 FTE
Commercial name
SERIE SA
Principal activity
Study, development of the production of active ingredients for drug manufacturing
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Serie

2024 2023 2022 2021
Profit/Loss -960,185 -67 % -576,006 22 % -739,280 -311 % -179,966
Equity 3,087,648 394 % -1,048,982 -123 % -469,792 -270 % 275,858
Gross margin 632,322 -24 % 828,492 326 % 194,619 -31 % 281,314

Publications from Serie

Date Publication
15-04-2022 General meeting (FR)
12-11-2021 Resignations, Appointments (FR)
06-06-2018 Resignations, Appointments (FR)
28-03-2012 Registered Office - Resignations, Appointments (FR)
24-07-2007 Augmentation(s) Capital Modification(s) Articles of Association (FR)

Frequently asked questions

What is the VAT number of Serie?
The VAT number of Serie is BE 0420.366.623.
Wat is the PEPPOL ID of Serie?
There is no information available about the PEPPOL ID of Serie or the company is not yet registered on the PEPPOL network.
When was Serie founded?
Serie was founded on 10-04-1980.
What is the address of Serie?
The current registered office of Serie is located at Rue De La Forge 10, 1470 Genappe.
When was the last time Serie filed their annual financial statements?
The most recent financial statements of Serie were filed on 30-06-2025.
How many employees does Serie have?
There are 1 FTEs working at Serie according to the staff figures in the most recent financial statements.
What is the annual turnover of Serie?
At the time of its most recent financial statements, Serie did not publish any turnover figures. Serie reported a gross margin of €632,322.38.